...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Amgen's Acclaimed 20% MACE reduction referred to as "slashing heart attack rates"

Exactly. 

 

The title was accurate. There was no significant mortality reduction. 

 

The drug is overpriced and will only be used sparingly. 

 

Bfw

Share
New Message
Please login to post a reply